Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Operating Expenses | 3,043 | 2,092 | 4,454 | 38,072 | 4,245 |
| Operating Income | -3,043 | -2,092 | -4,454 | -38,072 | -4,245 |
| Other Income | 444 | -1,627 | 142 | 114 | 82 |
| Pre-tax Income | -2,599 | -3,719 | -4,312 | -37,958 | -4,163 |
| Income Tax | -208 | -446 | -289 | -8,871 | -274 |
| Net Income Continuous | -2,391 | -3,273 | -4,023 | -29,087 | -3,889 |
| Net Income | $-2,391 | $-3,273 | $-4,023 | $-29,087 | $-3,889 |
| EPS Basic Total Ops | -0.21 | -0.43 | -0.54 | -3.92 | -0.52 |
| EPS Basic Continuous Ops | -0.21 | -0.43 | -0.54 | -3.91 | -0.52 |
| EPS Diluted Total Ops | -0.21 | -0.43 | -0.54 | -3.92 | -0.52 |
| EPS Diluted Continuous Ops | -0.21 | -0.43 | -0.54 | -3.91 | -0.52 |
| EBITDA(a) | $-3,042 | $-2,090 | $-4,447 | $-38,064 | $-4,235 |